Bath & Body Works (BBWI) to Post Quarterly Earnings on Wednesday

Key Points

• Bath & Body Works is expected to report Q2 2027 results before markets open on August 26, with analysts forecasting $0.242 in earnings per share and $1.497 billion in revenue.
• The company’s latest quarter exceeded expectations, posting $0.32 EPS and $1.38 billion in revenue, although sales declined 3.2% year over year.
• BBWI recently declared a quarterly dividend of $0.20 per share, implying a 4.0% annualized yield, while analysts maintain a consensus “Hold” rating and an average price target of $22.57.

Bath & Body Works (NYSE:BBWI - Get Free Report) is expected to post its Q2 2027 results before the market opens on Wednesday, August 26th. Analysts expect Bath & Body Works to announce earnings of $0.2420 per share and revenue of $1.4974 billion for the quarter. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Individuals are encouraged to explore the company's upcoming Q2 2027 earning overview page for the latest details on the call scheduled for Wednesday, August 26, 2026 at 8:30 AM ET.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.03. The company had revenue of $1.38 billion during the quarter, compared to analysts' expectations of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business's quarterly revenue was down 3.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.49 earnings per share. On average, analysts expect Bath & Body Works to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Bath & Body Works Stock Performance

BBWI opened at $20.12 on Wednesday. The company has a market cap of $4.05 billion, a PE ratio of 5.65, a price-to-earnings-growth ratio of 1.92 and a beta of 1.38. The stock has a 50-day moving average of $20.42 and a 200-day moving average of $20.13. Bath & Body Works has a 52-week low of $14.27 and a 52-week high of $32.32.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Friday, August 21st will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 4.0%. The ex-dividend date is Friday, August 21st. Bath & Body Works's payout ratio is 22.47%.

Analyst Ratings Changes

A number of brokerages have issued reports on BBWI. JPMorgan Chase & Co. upped their target price on Bath & Body Works from $22.00 to $24.00 and gave the stock a "neutral" rating in a research report on Tuesday. Citigroup raised shares of Bath & Body Works from a "neutral" rating to a "buy" rating and set a $25.00 price target on the stock in a research report on Tuesday. The Goldman Sachs Group cut shares of Bath & Body Works from a "neutral" rating to a "sell" rating and reduced their price objective for the stock from $23.00 to $19.00 in a research note on Wednesday, July 8th. Telsey Advisory Group decreased their price objective on shares of Bath & Body Works from $25.00 to $22.00 and set a "market perform" rating for the company in a report on Thursday, May 28th. Finally, Raymond James Financial reiterated a "market perform" rating on shares of Bath & Body Works in a research note on Wednesday, May 27th. Four research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Bath & Body Works presently has an average rating of "Hold" and an average price target of $22.57.

Institutional Trading of Bath & Body Works

A number of institutional investors and hedge funds have recently modified their holdings of BBWI. Invesco Ltd. increased its stake in Bath & Body Works by 43.6% in the fourth quarter. Invesco Ltd. now owns 652,991 shares of the company's stock valued at $13,112,000 after acquiring an additional 198,324 shares during the period. Corient Private Wealth LLC boosted its holdings in Bath & Body Works by 475.8% during the fourth quarter. Corient Private Wealth LLC now owns 97,202 shares of the company's stock valued at $1,952,000 after purchasing an additional 80,322 shares in the last quarter. Alberta Investment Management Corp bought a new stake in shares of Bath & Body Works in the 4th quarter valued at approximately $1,135,000. Mercer Global Advisors Inc. ADV raised its holdings in shares of Bath & Body Works by 39.3% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 161,935 shares of the company's stock worth $3,252,000 after buying an additional 45,713 shares in the last quarter. Finally, XTX Topco Ltd raised its holdings in shares of Bath & Body Works by 65.2% in the 4th quarter. XTX Topco Ltd now owns 80,548 shares of the company's stock worth $1,617,000 after buying an additional 31,781 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source